This brief scientific review presents the main provisions of molecular-genetic theory of carcinogenesis. The review contains data on the presence of supra-cellular mechanisms of regulation of tissue homeostasis, which can be explained from the perspective of molecular-genetic approach, as well as data on the interpretation of the dominant theory of carcinogenesis based on other pathogenetic mechanisms that allows the author to con-tinue developing of tissue theory of carcinogenesis. Modern concepts of structural and functional characteristics of the microcirculatory channel are described. In the review the author provides convincing data, including its own data on the oxygen therapy effect (normobaric and hyperbaric oxygen therapy), on modulation of antioxi-dant activity of the tumor, on controlled differentiation of malignant cells by means of surgical method (by changing antegrade blood flow in the retrograde through vascular reverse). The importance of microcirculatory level of tissue homeostasis is defined. The review describes the significance of hyper-expression of this gene in the gene for factor vascular endothelial growth in carcinogenesis and forming a secondary tumor micro-circulation. The author gives pathogenetic substantiation of anti-VEGF therapy of malignant tumors by bevaci-zumab from the point of view of tissue approach to carcinogenesis. The main provisions of microcirculatory tissue theory of carcinogenesis are formulated.
microcirculation, oxygen therapy, vascular reverse, molecular-genetic theory of carcinogenesis, tissue theory of carcinogenesis, secondary microvascular bed, lipid peroxidation, antioxidant activity of tumors, VEGF, anti-VEGF therapy, bevacizumab, microcirculatory-tissue theory of carcinogenesis.
1. Bagley E.A., Sidorik E.P. Antioksidanty i svobodnye radikaly lipidov pri opukholevom protsesse. Voprosy onkologii. 1970. T. 16. № 10. S. 95-107.
2. Gorbatsevich L.I., Timofeev N.N. O vnutriarterial´nom primenenii rastvorov perekisi vodo-roda v eksperimente i klinike. Vestnik khirurgii im. Grekova. 1972. T. 108. № 2. S. 119-123.
3. Dzasokhov S.V., Khadartsev A.A. K obosnovaniyu sposoba reversivnogo krovotoka. Vestnik novykh meditsinskikh tekhnologiy. 1997. № 3. S. 109-110.
4. Dzasokhov A.S. Patogeneticheskoe obosnovanie primeneniya oksigenoterapii v onkologii. Vestnik novykh meditsinskikh tekhnologiy. 2011. № 4. S. 196.
5. Dzasokhov A.S. Patogeneticheskie aspekty opukholevogo rosta v svete tkanevoy teorii kantsero-geneza (kratkiy literaturnyy obzor). Vestnik novykh meditsinskikh tekhnologiy. 2012. № 1. S. 179-181.
6. Dzasokhov A.S., Gerashchenko M.A. Sravnitel´naya kharakteristika vspomogatel´noy roli giperba-richeskoy oksigenatsii i normobaricheskoy oksigenatsii v lechenii toshnoty i rvoty pri tsitostaticheskoy terapii raka yaichnikov. Nauchnyy elektronnyy arkhiv akademii estestvoznaniya. URL: http://www.econf.rae.ru/article/6807. (data obrashcheniya 01.06.2012).
7. Dzasokhov A.S., Gerashchenko M.A. Polnaya regressiya raka sheyki matki IV stadii pri kompleksnom lechenii na fone giperbaricheskoy oksigenatsii (klinicheskiy sluchay). Sb. tezisov II konferentsii Obshchestva spetsialistov onkologov po opukholyam reproduktivnoy sistemy. Moskva, 2012. 26 s.
8. Dzasokhov A.S., Savkova R.F., Gerashchenko M.A. Effektivnost´ tsitostaticheskoy terapii retsi-diva raka endometriya na fone oksigenoterapii. Sb. tezisov II konferentsii Obshchestva spetsialistov onkologov po opukholyam reproduktivnoy sistemy. Moskva, 2012. 27 s.
9. Dolzhanskiy O.V., Vasyutin R.Yu., Savkova R.F., Yudina L.F., Dzasokhov A.S. Osobennosti degra-datsii RNK zlokachestvennykh opukholey yaichnikov. Vestnik novykh meditsinskikh tekhnologiy. 2010. № 3. S. 128-129.
10. Efuni S.N. Rukovodstvo po giperbaricheskoy oksigenatsii. M.: Meditsina, 1986.
11. Ivanov D.V., Khadartsev A.A. Kletochnye tekhnologii v vosstanovitel´noy meditsine / Pod red. A.N. Lishchuka. Tula: Tul´skiy poligrafist, 2011. 180 s.
12. Ivanov D.V., Khadartsev A.A. Kletochnye tekhnologii i sinergetika. Sistemnyy analiz i upravlenie v biomeditsinskikh sistemakh. 2009. T. 8. № 3. S. 751-754.
13. Kozyreva S.M., Kozyrev K.M. Rezul´taty kompleksnogo lecheniya bol´nykh rakom yaichnikov s primeneniem autogemokhimioterapii. Vestnik novykh meditsinskikh tekhnologiy. 2012. № 1. S. 68-71.
14. Lebedeva V.A. Sostoyanie sistemy perekisnogo okisleniya lipidov u bol´nykh rasprostranen-nym rakom yaichnikov v dinamike polikhimioterapii: Diss. … kand. med. nauk. Novosibirsk, 2002.
15. Polenov S.A. Osnovy mikrotsirkulyatsii. Regionarnoe krovoobrashchenie i mikrotsirkulyatsiya. 2008. T.7. № 1(25). S. 5-19.
16. Savkova R.F., Konstantinova M.M., Yudina L.F., Ol´kin B.I., Dzasokhov A.S. Sovremennye metody korrektsii anemii u bol´nykh, stradayushchikh rakom yaichnikov, v protsesse protivoopukholevogo le-cheniya. Vestnik novykh meditsinskikh tekhnologiy. 2008. № 1. S. 138-139.
17. Savkova R.F., Yudina L.F., Gerashchenko M.A., Dzasokhov A.S. Giperbaricheskaya oksigenatsiya v lechenii khimiorezistentnykh retsidivov sarkomy i raka tela matki. Vestnik novykh meditsinskikh tekh-nologiy. 2008. № 3. S. 41.
18. Savkova R.F., Yudina L.F., Gerashchenko M.A., Dzasokhov A.S. Ob´´ektivizatsiya i lechenie bolevogo sindroma pri tsitostaticheskoy terapii retsidivov raka sheyki matki na fone giperbaricheskoy oksi-genatsii. Vestnik novykh meditsinskikh tekhnologiy. 2010. № 1. S. 62-63.
19. Savkova R.F., Yudina L.F., Gerashchenko M.A., Dzasokhov A.S. Giperbaricheskaya oksigenatsiya v kompleksnom lechenii raka sheyki matki. Nauchnyy elektronnyy arkhiv akademii estestvoznaniya. URL: http://www.econf.rae.ru/article/6796 (data obrashcheniya 31.05.2012).
20. Savkova R.F., Yudina L.F., Dzasokhov A.S., Gerashchenko M.A. Dinamika regressii metastazov v legkie pri tsitostaticheskoy terapii retsidivov raka endometriya na fone giperbaricheskoy oksigenatsii. Nauchnyy elektronnyy arkhiv akademii estestvoznaniya. URL: http://www.econf.rae.ru/article/6797 (data obrashcheniya 31.05.2012).
21. Savkova R.F., Yudina L.F., Dzasokhov A.S., Gerashchenko M.A. Korrelyatsiya effekta khimioterapii i razmerov metastazov v legkie pri tsitostaticheskoy terapii retsidivov raka yaichnikov. Nauchnyy elek-tronnyy arkhiv akademii estestvoznaniya. URL: http://www.econf.rae.ru/article/6805 (data obrashcheniya 01.06.2012).
22. Savkova R.F., Yudina L.F., Dzasokhov A.S., Gerashchenko M.A. Sravnitel´naya kharakteristika me-todov oksigenoterapii u bol´nykh, poluchayushchikh tsitostaticheskuyu terapiyu pri kombinirovannom leche-nii raka yaichnikov. Nauchnyy elektronnyy arkhiv akademii estestvoznaniya. URL: http://www.econf.rae.ru/article/6808. (data obrashcheniya 01.06.2012).
23. Savkova R.F., Rotobel´skaya L.E., Yudina L.F., Gerashchenko M.A., Dzasokhov A.S. Oksigenotera-piya kak dopolnitel´nyy komponent tsitostaticheskogo lecheniya retsidivov raka sheyki matki. Opukholi zhenskoy reproduktivnoy sistemy. 2012. № 3-4. S. 160-164.
24. Subbotina T.I., Khadartsev A.A., Ivanov D.V., Savin E.I., Konstantinova D.A., Panteleeva A.Yu. Usilenie aktivnosti proliferatsii i differentsirovki stvolovykh kletok pri vozdeystvii na organizm EMI KVCh. Mezhdunarodnyy zhurnal prikladnykh i fundamental´nykh issledovaniy 2011. № 12. S. 108-109.
25. Khadartsev A.A., Gerashchenko M.A., Savkova R.F., Yudina L.F., Dzasokhov A.S. Obosnovanie pri-meneniya giperbaricheskoy i normobaricheskoy oksigenatsii v onkoginekologii //I Mezhdunarodnaya nauch-no-prakticheskaya konferentsiya «Innovatsionnye tekhnologii upravleniya zdorov´em i dolgoletiem chelo-veka» (Sankt-Peterburg, 8-9 aprelya 2010 g.). SPb., 2010. S. 393-395.
26. Khadartsev A.A., Gerashchenko M.A., Dzasokhov A.S. Opyt primeneniya metodov kislorodoterapii v onkoginekologii. Sb. tezisov I konferentsii Obshchestva spetsialistov onkologov po opukholyam repro-duktivnoy sistemy. Moskva, 2011, S. 77-78.
27. Mediko-biologicheskaya teoriya i praktika. Khadartsev A.A., Es´kov V.M., Kozyrev K.M. [i dr.]/ Pod. red. V.G. Tyminskogo. Tula: izd-vo TulGU - Belgorod: ZAO «Belgorodskaya oblastnaya tipografiya», 2011. 232 s.
28. Cherezov A.E. Obshchaya teoriya raka. Tkanevyy podkhod. M.: Izdatel´stvo MGU, 1997.
29. Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment / Busk M., Wa-lenta S., Mueller-Klieser W., Steiniche T. [et al.]. Radiother Oncol. 2011. 99. P. 404-411.
30. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003. 9. R. 669-676.
31. Griffin J.L., Shockcor J.P. Metabolic profiles of cancer cells. Nat Rev Cancer. 2004. 4 (7). R. 551-561.
32. Expression of the angiopoetin-1, angiopoetin-2, Tie-2 and vascular endothelian growth factor gene in epitelian ovarian cancer / Hata K., Nakayama K. [et al.]. Gynecol Oncol. 2004. 93. P. 215-222.
33. Expression of the vascular endothelial growth factor (VEGF) gene in epithelial ovarian cancer: an ap-proach to anti-VEGF therapy / Hata K., Watanabe Y. [et al.]. Anticancer Res. 2011. 31(2). R. 731-737.
34. Mattern J., Stammler G., Koomagi R., Wallwiener D., Kaufmann M., Volm M. Spontaneous apopto-sis in ovarian cancer: an unfavorable prognostic factor. Int J Oncol. 1998. 12(2). R. 351-354.
35. Mueller-Klieser W., Schaefer C., Walenta S., Rofstad E.K., Fenton B.M., Sutherland R.M.. Assess-ment of tumor energy and oxygenation status by bioluminescence, nuclear magnetic resonance spectroscopy, and cryospectrophotometry. Cancer Res. 1990. 50(6). P. 1681-1685.
36. Mujcic H., Rzymski T., Rouschop K.M., Koritzinsky M., Milani M., Harris A.L., Wouters B.G.. Hy-poxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3.. Radiother Oncol. 2009. 92(3). R. 450-459.
37. Owen M.R., Byrne H.M., Lewis C.E. Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites. J Theor Biol. 2004. 226(4). R. 377-391.
38. Petre P.M., Baciewicz F.A. Jr, Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of metastatic lung tumors in a rat model. J Thorac Cardiovasc Surg. 2003. 125 (1). R. 85-95.
39. Raab S.S., Grzybicki D.M. Cytologic-histologic correlation. Cancer Cytopathol. 2011. 119. R. 293-309.
40. Xu L., Xie K., Mukaida N., Matsushima K., Fidler I.J. Hypoxia-induced elevation in interleukin-8 ex-pression by human ovarian carcinoma cells. Cancer Res. 1999. 59 (22). R. 5822-5829.
41. Yang Z.F., Poon R.T., To J., Ho D.W., Fan S.T. The potential role of hypoxia inducible factor 1-alpha in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma. Cancer Res. 2004. 64(15). R. 5496-5503.
42. Yetkin F.Z., Mendelsohn D. Hypoxia imaging in brain tumors. Neuroimaging Clin N Am. 2002. 12(4). P. 537-552.